SandraS.WerbelMD

Diabetes, Lipid Metabolism

Accent Endocrinology

Dr. Werbel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4340 Newberry Rd
Ste 301
Gainesville, FL 32607
Phone+1 352-372-9414

Fax+1 352-271-5393

Wake Forest University Baptist Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 1992 - 1995
Wake Forest University Baptist Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1994
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1989 - 1992
Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1989 - 1990
University of Florida College of MedicineClass of 1989

CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012
Fellow (FACE) American Association of Clinical Endocrinology

PubMed

155 citations
Contribution of visceral fat mass to the insulin resistance of aging.
William T. Cefalu, Zhong Q. Wang, Sandra Werbel, Audrey D. Bell-Farrow, John R. Crouse
Metabolism. 1995-07-01
100 citations
Pheochromocytoma. Update on diagnosis, localization, and management.
Sandra Werbel, K. Patrick Ober
The Medical Clinics of North America. 1995-01-01
24 citations
Insulin resistance and fat patterning with aging: Relationship to metabolic risk factors for cardiovascular disease
William T. Cefalu, Sandra Werbel, Audrey D. Bell-Farrow, James G. Terry, Zhong O. Wang
Metabolism. 1998-04-01

Inhaled VS Subcutaneous Intensive Insulin In NIDDMNational Center For Research Resources2000–2002
Inhaled VS Subcutaneous Insulin In Type I DiabetesNational Center For Research Resources2000–2002
Inhaled VS Subcutaneous Human Insulin In Type II DiabeteNational Center For Research Resources2000–2002
Inhaled Human Insulin VS Usual SQ Insulin In Type II Diabetes MellitusNational Center For Research Resources2000–2002
Inhaled Human Insulin VS Usual SQ Insulin In Type I Diabetes MellitusNational Center For Research Resources2000–2002
Inhaled Human Insulin As Adjunctive Therapy In Subjects With Type 2 DiabetesNational Center For Research Resources2000–2002
Diabetes Prevention TrialNational Center For Research Resources1996–2002